Ballard trach care HMES and filters, tv 1500, HME with built-in flex tube
Indications For Usage: , ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hou
Indications For Usage:, ,Single use on tracheostomy patients who can breathe spontaneously. The product is intended to be replaced at least once every 24 hours.
...eg; Thermovent® T helps provide protection to ... is small and extremely lightweight making it idea...h a high rate of heat and moisture recovery, it en...ion., ,All HMEs and filters have ISO standard tap...
Medicine Products:(Date:9/5/2008)...ane Shows Public Reluctant to Evacuate, Without Th...forts Confirm Survey R...rvey by the American Humane,Association found that...tance if it meant leaving without their family pet...towards the U.S. coast, residents and,officials sh...
(Date:9/5/2008)...swire/ -- Arthrosurface, Inc.,( http://www.arthros...,resurfacing systems, announced that it has receiv... investigation for its line of focal knee,resurfac...tstanding safety,concerns" with the device and gra...n evaluating the safety and efficacy of its,HemiCA...
(Date:9/5/2008)...swire/ -- On Saturday, September 6, PARI,Respirato...k show Today,s,Family as part of their "Breathe Ea...ical device company that provides patients, such a...mpressors that deliver needed,medications directly...es of those affected by respiratory,diseases and t...
(Date:9/5/2008)...ose overweight or obese at age 45 , , FR...ll American adults will develop osteoarthritis of ...y are obese in middle age, a new study says. ,...ncreased as his or her body-mass index (BMI) rose,...Chapel Hill study. People who were of normal weigh...
Breaking Medicine News(10 mins):Health News:Nearly Half of Americans Won't Flee Without Fido 2Health News:Nearly Half of Americans Won't Flee Without Fido 3Health News:Nearly Half of Americans Won't Flee Without Fido 4Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2(Date:9/4/2008)...ancet, and Presented at ESC Congress-, PHILADELPH...ernational,study, the GISSI Heart Failure (GISSI-H...thyl esters reduced all cause mortality and hospit...ts with chronic heart,failure. These findings are ...ncet, and were presented at the European Cardiovas...
(Date:9/4/2008)...RNewswire/ -- Southern Research Institute,today an...H) has selected,the organization to participate in...tion Center Network (MLPCN). The MLPCN -- a collab...ar Libraries Program which is,designed to benefit ...human,genome and validate future targets for drug ...
(Date:9/4/2008)...er 4 /- Axentis Pharma AG has,initiat... and tolerability,of a new therapeutic formulation...n cystic fibrosis patients. The new formulation al...red directly to the site of,infection. The forthco...fferent doses of the new drug. Initial results are...
(Date:9/4/2008)...ent antiviral activity and favorable safety ...s., Sept. 4 /- Idenix,Pharm...ical company engaged,in the discovery and developm...other infectious diseases, today announced that it...ng IDX899, a non-nucleoside reverse,transcriptase ...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4American Chemical Societys Weekly Presspac Oct 17 2007 4232 1American Chemical Societys Weekly Presspac Oct 17 2007 4232 2American Chemical Societys Weekly Presspac Oct 17 2007 4232 3American Chemical Societys Weekly Presspac Oct 17 2007 4232 4American Chemical Societys Weekly Presspac Oct 17 2007 4232 5American Chemical Societys Weekly Presspac Oct 17 2007 4232 6American Chemical Societys Weekly Presspac Oct 17 2007 4232 7American Chemical Societys Weekly Presspac Oct 17 2007 4232 8Space sensors shed new light on air quality 4229 1Space sensors shed new light on air quality 4229 2Space sensors shed new light on air quality 4229 3Long Term Care Newsletter Debuts Published by LTC Financial Partners 3B Advice on Living Better Not Just Longer With Financial Protection 4226 1Long Term Care Newsletter Debuts Published by LTC Financial Partners 3B Advice on Living Better Not Just Longer With Financial Protection 4226 2Schering Plough Reports Financial Results for Third Quarter of 2007 4223 1Schering Plough Reports Financial Results for Third Quarter of 2007 4223 2Schering Plough Reports Financial Results for Third Quarter of 2007 4223 3Schering Plough Reports Financial Results for Third Quarter of 2007 4223 4Schering Plough Reports Financial Results for Third Quarter of 2007 4223 5Schering Plough Reports Financial Results for Third Quarter of 2007 4223 6Schering Plough Reports Financial Results for Third Quarter of 2007 4223 7Schering Plough Reports Financial Results for Third Quarter of 2007 4223 8Schering Plough Reports Financial Results for Third Quarter of 2007 4223 9Schering Plough Reports Financial Results for Third Quarter of 2007 4223 10Schering Plough Reports Financial Results for Third Quarter of 2007 4223 11Schering Plough Reports Financial Results for Third Quarter of 2007 4223 12Schering Plough Reports Financial Results for Third Quarter of 2007 4223 13Schering Plough Reports Financial Results for Third Quarter of 2007 4223 14Schering Plough Reports Financial Results for Third Quarter of 2007 4223 15Schering Plough Reports Financial Results for Third Quarter of 2007 4223 16Schering Plough Reports Financial Results for Third Quarter of 2007 4223 17Schering Plough Reports Financial Results for Third Quarter of 2007 4223 18.... Jude study shows mesenchymal cells in bone marro...gine, restoring this,critical nutrient when it is ... Tenn., March 22, 2007 /PRNewswire/ -- The cancer ... with acute,lymphoblastic leukemia (ALL) because m...row counteract the effect of that drug,according ...
...Homozygous FH patients already being treated with ...ienced 50% further,reductions in LDL-C with simila...h 300 mg/week ISIS 301012, NEW ORLEANS, and CARLSB...-- Isis Pharmaceuticals, Inc. announced,results fr...12 in,patients with homozygous familial hyperchole...
Other Medicine Technology:Leukemic Cells Find Safe Haven in Bone Marrow 2Leukemic Cells Find Safe Haven in Bone Marrow 3Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 2Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 3Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 4Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 6